Welcome to our dedicated page for Carter Bankshares SEC filings (Ticker: CARE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Carter Bankshares, Inc. filings document the company’s role as the holding company for Carter Bank, its CARE common stock listed on the Nasdaq Global Select Market, and recurring bank disclosures on results of operations, financial condition, investor presentations, capital returns, and asset quality. Form 8-K reports cover quarterly results, Regulation FD presentations, dividend actions, completed loan and asset sales, and other material events.
Proxy materials disclose board matters, executive compensation, equity awards, shareholder voting items, and governance practices. The filings also address bank-specific disclosures tied to credit performance, liquidity, capital levels, regulatory oversight, loan portfolio composition, and forward-looking statements used in financial and strategic reporting.
Catharine L. Midkiff, a director of Carter Bankshares (CARE), reported a sale of 2,000 shares of common stock on 07/30/2025 at approximately $17.76 per share, leaving her with 16,054 shares beneficially owned. The filing notes that 200 of the sold shares matched a purchase on 06/02/2025, producing $258 in short-swing profits that the reporting person voluntarily disgorged to the issuer.
The explanation states the matched sale was inadvertently within six months of the earlier acquisition to the extent of 200 shares and that the reporting person has remedied the matter by returning the realized profits to the company. The Form 4 is signed by an attorney-in-fact.
Carter Bankshares disclosed that Chief Executive Officer Litz H. Van Dyke shared a letter with employees informing them of a recent medical update. The company furnished that letter as Exhibit 99.1 under a Regulation FD disclosure. The filing contains no financial metrics, operating details, transaction information, or statements about changes to leadership, succession plans, or business operations. The report is signed on the company’s behalf by Chief Financial Officer Wendy S. Bell. The 8-K therefore communicates the CEO’s employee-facing medical update without providing any information about material impacts to the company’s financial position or operations.
Carter Bankshares (CARE) director James W. Haskins reported an open-market sale of 2,000 common shares on 07/28/2025 at $17.84 each.
- Gross proceeds: ≈$35,680.
- Post-sale holdings: 61,900 shares held directly and 1,751 shares held indirectly through his spouse.
- No derivative securities were reported.
The filing signals a modest reduction in insider ownership but the director retains a sizeable stake, maintaining alignment with shareholders.